# CARMUSTINE
> **ANDA211011** · Abbreviated New Drug Application (Generic) · Sponsor: NOVAST LABS · Approved 2022-06-21
## Drug
- **FDA Application Number:** ANDA211011
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CARMUSTINE
- **Generic name:** Carmustine
- **Active ingredients:** CARMUSTINE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Discontinued
- **Sponsor:** NOVAST LABS
- **First approval:** 2022-06-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211011)
---
*AI Analytics · CC0 1.0*